media
2022-02-10 // A small Seattle biotech wants to take on GlaxoSmithKline’s emerging Shingrix blockbuster
Go to Article
2022-02-07 // Univercells campus in Jumet ready to produce vaccines
Go to Article
2022-01-27 // Moderna, Excision each enter HIV battle with mRNA and CRISPR tech
Go to Article
2021-12-20 // The Gates Foundation brings new funding to Univercells
Go to Article
2021-11-02 // Global vision for women’s health lands Peninsula biotech $31M
Go to Article
2021-09-16 // African genomics startup 54gene raises $25M to expand precision medicine capabilities
Go to Article
2021-07-06 // The First Close Podcast: Jenny Yip from Adjuvant Capital
Go to Article
2021-06-10 // Covid Led To A Record Year For Funding Infectious Disease Companies —Will That Continue?
Go to Article
2021-05-17 // The Full Ratchet Podcast: The Future of Public Health, VC Differentiation within Life Sciences, and Preventing the Next Pandemic (Glenn Rockman)
Go to Article
2021-02-24 // Bringing the VC approach to global health
Go to Article
2021-02-24 // Six years separated from a rabies vaccine scandal, China’s YishengBio grabs $130M to go big in infectious diseases, cancer
Go to Article
2021-02-18 // Pandemic Stokes Interest in Gates-Backed Public Health Fund
Go to Article
2021-02-18 // Adjuvant Capital Raises $300 Million Global-Health Venture Fund
Go to Article
2021-02-18 // VC style returns on ‘unsexy’ public health bets? Gates-backed Adjuvant Capital gathers $300M to mend a ‘failure of imagination’
Go to Article
2021-02-18 // Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases
Go to Article
2021-02-18 // Public Health-focused Adjuvant Capital, Backed by Merck & Gates, Raises $300m
Go to Article
2021-02-18 // Investors put $300 million into Adjuvant Capital as global health innovation shines
Go to Article
2021-02-18 // New $300 Million Venture Fund Spotlights Role Of Women In Venture Capital And Public Health
Go to Article
2021-02-18 // Investment firm raises $300M to fund medical research for overlooked diseases
Go to Article
2020-12-14 // Codagenix, Serum Institute to begin UK trials of nasal COVID-19 vaccine in January
Go to Article
2020-10-15 // Evofem Biosciences Secures $25 Million Strategic Investment from Adjuvant Capital
Go to Article
2020-09-22 // India’s Serum Institute starts manufacturing Codagenix’s potential COVID-19 vaccine
Go to Article
2020-09-11 // Merck Covid-19 Vaccine Begins Human Testing
Go to Article
2020-09-16 // Synthetic biologists have created a slow-growing version of the coronavirus to give as a vaccine
Go to Article
2020-04-14 // African genomics startup 54gene raises $15M led by Adjuvant Capital
Go to Article
2020-04-14 // To accelerate innovation, the CDC should ease limits on which labs can handle the coronavirus
Go to Article
2020-04-14 // 54gene Closes $15M Series A
Go to Article
2020-04-10 // A New Front for Nationalism: The Global Battle Against a Virus
Go to Article
2020-03-24 // Private equity firms go after covid-19, repurposing portfolio company resources
Go to Article
2020-03-13 // Venture Capitalists Shun Unprofitable Yet World-Saving Vaccines
Go to Article
2020-02-13 // Codagenix and Serum Institute of India Initiate Co-Development of a Scalable, Live-Attenuated Vaccine Against the 2019 Novel Coronavirus, COVID-19
Go to Article
2020-01-14 // Gates vets at Adjuvant back Codagenix’s software-driven approach to recoding RSV, fly oncolytic viruses and more
Go to Article
2020-01-13 // Codagenix raises $20 million for a new flu vaccine and other therapies
Go to Article
2019-11-21 // AN2 Therapeutics Raises $12M in Series A Funding
Go to Article
2019-11-21 // AN2 Therapeutics Launches with $12 Million in Series A Funding and Announces a Strategic Partnership with Brii Biosciences
Go to Article
2019-09-23 // Financing Global Health
Go to Article
2019-09-18 // Themis raises €40M to run phase 3 chikungunya vaccine trial
Go to Article
2019-09-10 // InDevR Raises $7 Million in Series A Financing With Adjuvant Capital
Go to Article